Package leaflet: Information for the user

Similar documents
Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

Module Page 1 of 1

2. What you need to know before Marcain Polyamp Steripack is given to you

1. What Xylocaine with adrenaline is and what it is used for

PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER. chloroprocaine hydrochloride

Package leaflet: Information for the user Lidocaine 1% w/v, 2% w/v solution for injection (Lidocaine Hydrochloride)

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER. Prilotekal 20 mg/ml solution for injection prilocaine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ropivakain Sintetica 5 mg/ml solution for injection ropivacaine hydrochloride

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

1. What Naropin is and what it is used for

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

Package leaflet: Information for the user. {Product name} 100 mg/100 mg/1 mg/20 mg/2 ml solution for injection

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Package leaflet: Information for the patient. Scandonest 3% w/v, Solution for Injection Mepivacaine hydrochloride

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

B. PACKAGE LEAFLET R001 1

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Package leaflet: Information for the patient. Lacosamide G.L. 10 mg/ml solution for infusion lacosamide

Package leaflet: Information for the user 1% w/v Lidocaine Hydrochloride Injection BP Lidocaine Hydrochloride

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

TREANA 5mg and 10mg Film-coated Tablets

Package leaflet: Information for the user. Paralink 10 mg/ml Solution for Infusion Paracetamol

NITHIODOTE Solution for Injection. Active Substances Sodium Nitrite and Sodium Thiosulfate

PATIENT INFORMATION LEAFLET. DOTAREM mg/ml, solution for injection (Gadoteric acid)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection

Package leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose

Package leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

1. What Miacalcic is and what it is used for

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. ANESDERM 25 mg/g + 25 mg/g Cream Lidocaine, Prilocaine

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

HERNOVIR 200 mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol

Package leaflet: Information for the user

Package leaflet: Information for the user. Optiray 320 mg I/ml, solution for injection or infusion. Active substance: Ioversol

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the patient

Package leaflet: Information for the patient

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

Package leaflet: Information for the user. Midazolam 2 mg/ml Solution for Injection or Infusion Midazolam 5 mg/ml Solution for Injection or Infusion

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

NORVASC 5 mg and 10 mg tablets

Package leaflet: Information for the user. Lidocaine Hydrochloride Anhydrous 2% w/v Adrenaline (epinephrine) 1:80,000

Package leaflet: Information for the user. Chirocaine 2.5 mg/ml and 5.0 mg/ml solution for injection/concentrate for solution for infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid

Package leaflet: Information for the user. Calcium Folinate 10 mg/ml, solution for injection Calcium folinate

Package leaflet: Information for the user. Rhesonativ 625 IU/ml, solution for injection Human anti-d immunoglobulin

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Patient leaflet: Information for the user. Cytarabine 20mg/ml and 100mg/ml Solution for infusion or injection (Cytarabine)

1 What Engerix B is and what it is used for

Package leaflet: Information for the patient. Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine

Package leaflet: Information for the user

Ventolin Injection 500 micrograms/ml salbutamol sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. NALOXONE 400 microgram/ml solution for injection or infusion. naloxone hydrochloride

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET. Testosterone Enantate 250mg/ ml Solution for Injection Testosterone Enantate

PATIENT INFORMATION LEAFLET. MIDORYX (MIDAZOLAM INJECTION 5mg, 10mg BP)

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Irbenida H 150mg/12,5mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

Package leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Piperacillin Tazobactam 4g/0.5g powder for solution for injection or infusion Piperacillin and tazobactam

Package leaflet: Information for the user

Transcription:

Package leaflet: Information for the user Lidocaine Accord 10 mg/ml solution for injection Lidocaine Accord 20 mg/ml solution for injection Lidocaine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet See section 4. What is in this leaflet: 1. What Lidocaine Accord is and what it is used for 2. What you need to know before you are given Lidocaine Accord 3. How Lidocaine Accord is given 4. Possible side effects 5. How to store Lidocaine Accord 6. Contents of the pack and other information 1. What Lidocaine Accord is and what it is used for Lidocaine Accord is a local anaesthetic. It is used to numb parts of the body during small surgical procedures. It stops the nerves from being able to pass pain messages to the brain and so stops you feeling pain. It starts to work a few minutes after being injected and slowly wears off when the surgical procedure is over. 2. What you need to know before you are given Lidocaine Accord You should not be given this medicine: if you are allergic to lidocaine hydrochloride, to local anaesthetics of the amide type or any of the other ingredients of this medicine (listed in section 6) if you have very low blood pressure, or if you have lost too much blood or other body fluids or your heart is unable to pump enough blood for other reasons, you should not get Lidocaine Accord injected into your spine. Speak to your doctor if one of these applies to you before you are given this medicine. Warnings and precautions Talk to your doctor or pharmacist or nurse before using Lidocaine Accord if you are elderly or in a generally debilitated condition if you suffer from any heart problems such as a slow or irregular heart beat or heart failure. If you suffer from lung or breathing disorder. if you suffer from any liver disease or kidney problems. if you suffer from fits (epilepsy). if you have inflammation or infection in the area to be injected. if you have porphyria (a rare inherited disease that affects the skin and

nervous system). if you have problems with blood clotting if you are in the last three month of pregnancy If you are not sure if any of the above applies to you, talk to your doctor before having a Lidocaine Accord. Other medicines and Lidocaine Accord Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. In particular, tell your doctor if you are taking any of the following medicines: other local anaesthetics. medicines used in the treatment of stomach or duodenal ulcers (e.g. cimetidine). medicines used to treat irregular heart beat (e.g. amiodarone). Pregnancy and breast-feeding If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines Depending on dose and administration, Lidocaine Accord can have temporary effect on your ability to drive or use machinery. Ask your doctor when it would be safe to resume these activities. Lidocaine Accord contains Sodium Each ml of solution for injection contains approximately 0.118 mmol sodium (if the strength 10 mg/ml is used) or 0.082 mmol sodium (if the strength 20 mg/ml is used). To be taken into consideration by patients on a sodium controlled diet. 3. How Lidocaine Accord is given Lidocaine Accord will be given to you by a doctor. It will be given to you as an injection into a vein, a muscle, under the skin, or into the epidural space near the spinal cord. The dose that your doctor gives you will depend on the type of pain relief that you need. It will also depend on your body size, age, physical condition and the part of your body that the medicine is being injected into. You will be given the smallest dose possible to produce the required effect. Use in children and adolescents The dose should be reduced in children and patients in reduced general condition. Lidocaine Accord will usually be given near the part of the body to be operated on. If you have given too much Lidocaine Accord The doctor treating you is trained to deal with serious side effects from getting too much Lidocaine Accord. The first signs of being given too much Lidocaine Accord are usually as

follows: - convulsions, - restlessness, - feeling dizzy or light-headed, - nausea, - numbness or tingling sensations of the lips and around the mouth, - problems with sight. If any of these happen to you, or you think you have received too much Lidocaine Accord, tell your doctor or nurse immediately. More serious side effects from being given too much Lidocaine Accord may follow, such as balance and coordination disorders, auditory changes, euphoria, confusion, problems with your speech, paleness, sweating, trembling, convulsions, effects on your heart and blood vessels, loss of consciousness, coma and stopping breathing for a short while (apnoea). If you have any further questions on the use of this product, ask your doctor. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor or nurse immediately if you have a severe allergic reaction (angioedema or anaphylactic shock). The signs may include sudden onset of: - swelling of your face, lips, tongue or throat; this may make it difficult to swallow, - severe or sudden swelling of your hands, feet and ankles, - difficulty breathing, - severe itching of the skin (with raised lumps), - fever, - fall in blood pressure. These side effects are rare (may affect up to 1 in 1000 people). Other possible side effects: Very common (may affect more than 1 in 10 people) - Low blood pressure - Nausea Common (may affect up to 1 in10 people) - Pins and needles - Dizziness - Slow heart beat - High blood pressure - Vomiting Uncommon (may affect up to 1 in 100 people) - Convulsions - Numbness of the tongue or tingling sensations around the mouth - Ringing in the ears or being sensitive to sound - Visual disturbances - Loss of consciousness - Tremor

- Drowsiness - Light-headedness - Tinnitus - Feeling of intoxication - Difficulty in speaking Rare (may affect up to 1 in 1000 people) - Hypersensitive reactions such as hives (urticaria), rash, angioedema and in severe cases anaphylactic shock - Changes in sensations or muscle weakness (neuropathy) - Inflammation of a membrane surrounding the spinal cord (arachnoiditis) which can cause pain in the lower back, or pain, numbness or weakness in the legs - Double vision - Irregular or stopped heart beat - Slowed or stopped breathing Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Lidocaine Accord Keep this medicine out of the sight and reach of children. This medicinal product does not require any special storage conditions. Do not use this medicine after the expiry date which is stated on the ampoule/vial and carton label after EXP. The expiry date refers to the last day of that month. For single use only, used immediately after first opening, discard any unused contents. Do not use this medicine if you notice the contents are discoloured in any way. The solution for injection should not be used if there are particles present. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Lidocaine Accord contains The active substance is lidocaine hydrochloride. Lidocaine Accord 10 mg/ml solution for injection: 1 ml of solution for injection contains 10 mg of lidocaine hydrochloride. Lidocaine Accord 20 mg/ml solution for injection: 1 ml of solution for injection contains 20 mg of lidocaine hydrochloride. The other ingredients are sodium chloride, hydrochloric acid (for ph adjustment), sodium hydroxide (for ph adjustment) and water for injections.

What Lidocaine Accord looks like and the contents of the pack Lidocaine Accord is a clear, colourless, sterile solution for injection. It is available in two strengths, 10 mg/ml and 20 mg/ml. Lidocaine Accord 10 mg/ml solution for injection is available in Glass ampoules: Glass vials: 5 x 2 ml, 10 x 2 ml, 20 x 2 ml 5 x 5 ml, 10 x 5 ml, 20 x 5 ml 10 x 10 ml, 20 x 10 ml 1 x 20 ml Lidocaine Accord 20 mg/ml solution for injection is available in Glass ampoules: Glass vials: 5 x 2 ml, 10 x 2 ml, 20 x 2 ml 5 x 5 ml, 10 x 5 ml, 20 x 5 ml 5 x 10ml, 10 x 10 ml, 20 x 10 ml 1 x 20 ml Not all pack sizes may be marketed. Marketing Authorisation Holder < To be completed nationally> Manufacturer < To be completed nationally> This medicinal product is authorised in the Member States of the EEA under the following names: Country Invented Name SE Lidocaine Accord AT Lidocain Accord 10 mg/ml, 20 mg/ml injektionslösung BE Lidocaine Accord 10 mg/ml, 20 mg/ml oplossing voor injectie / solution injectable/ injektionslösung BG Lidocaine Accord 10 mg/ml, 20 mg/ml solution for injection CY Lidocaine Accord 10 mg/ml, 20 mg/ml solution for injection DE Lidocain Accord 10 mg/ml Injektionslösung Lidocain Accord 20 mg/ml Injektionslösung DK Lidocain Accord 10 mg/ml, 20 mg/ml injektionsvæske, opløsning EE Lidocaine Accord ES Lidocaína Accord 10 mg/ml, 20 mg/ml solución inyectable FI Lidocaine Accord 10 mg/ml, 20 mg/ml injektioneste, liuos FR Lidocaine Accord 10 mg/ml, 20 mg/ml solution injectable IT Lidocaina Accord LT Lidocaine Accord 10 mg/ml, 20 mg/ml injekcinis tirpalas LV Lidocaine Accord 20 mg/ml šķīdums injekcijām NL Lidocaine Accord 10 mg/ml, 20 mg/ml oplossing voor injectie NO Lidocaine Accord 10 mg/ml, 20 mg/ml injeksjonsvæske, oppløsning PL Lidocaine Accord 10 mg/ml, 20 mg/ml PT Lidocaína Accord 10 mg/ml, 20 mg/ml This leaflet was last revised in 25 October 2017.

< To be completed nationally> ----------------------------------------------------------------------------------------------- The following information is intended for healthcare professionals only: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. For single use only, used immediately after first opening, discard any unused contents. Do not use this medicine if you notice the contents are discoloured in any way. The solution for injection should not be used if there are particles present. Method of administration Lidocaine Accord should only be used by, or under the supervision of, doctors with experience of regional anaesthesia and resuscitative skills. Facilities for resuscitation should be available when administering local anaesthetics. Please refer to the summary of product characteristics for posology information.